Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Early Breast Cancer
Interventions: DRUG: neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screenning
Sponsor: Peking University People's Hospital